ARDXArdelyx, Inc.

$3.82

The financials

Ardelyx, Inc. by the numbers

Ardelyx, Inc. (ARDX) reported revenue of $94M in Q1 2026 (quarter ended March 31, 2026), up 27% from the same quarter a year earlier. That came with a gross margin of 95% and net loss of $38M. For the full year FY2025, revenue was $407M (+22% year on year) and net income −$62M. Its largest product in 2026-Q1 was Product IBSRELA at $70M, 73% of the disclosed total, just ahead of Product XPHOZAH at 24%.

Ardelyx, Inc. income statement, Q1 2026 against the same quarter a year earlier
Income statementQ1 2026Q1 2025Change
Revenue$94M$74M+27%
Gross profit$90M$62M+45%
Operating income−$33M−$36Mn/a
Net income−$38M−$41Mn/a
Diluted EPS−$0.15−$0.17n/a
Revenue by product, 2026-Q1, as reported to the SEC
ProductRevenueShare
Product IBSRELA$70M73%
Product XPHOZAH$23M24%
Product And Service Other$1.1M1.2%
Non Cash Royalty Related To Sale Of Future Royalties$695K0.7%
Product Supply$354K0.4%
License$51K0.1%

Business Segments

Revenue split by product segment, from SEC XBRL filings.

Latest period: Q1 2026Total $95.6M (-16%)
Product IBSRELA grew +58% year on yearLicense -99% year on year
  • Product IBSRELA$70.1MQoQ -10%year on year +58%
  • Product XPHOZAH$23.3MQoQ -15%year on year -0.48%
  • Product And Service Other$1.1MQoQ -77%year on year -83%
  • Non Cash Royalty Related To Sale Of Future Royalties$695.0KQoQ -80%year on year -32%
  • Product Supply$354.0KQoQ -year on year +39%
  • License$51.0KQoQ +104%year on year -99%
Segment sum = 101% of reported consolidated revenue · Latest source: 10-Q filed 2026-04-30, SEC EDGAR